Celldex to Report Fourth Quarter and Year-End 2015 Business/Financial Results and Host 2016 Corporate Strategy Conference Call
The conference call and presentation will be webcast live over the
A replay of the call will be available approximately two hours after the live call concludes through
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.
Sarah CavanaughVice President of Investor Relations & Corp Communications Celldex Therapeutics, Inc.(781) 433-3161 firstname.lastname@example.org Charles LilesManager of Investor Relations & Corp Communications Celldex Therapeutics, Inc.(781) 433-3107 email@example.com
News Provided by Acquire Media